missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human IL-21 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Marca: R&D Systems™ 8879-IL-010
318.40 EUR valido fino al 2025-07-30
Usa il codice promo "24078" per avere il tuo prezzo promozionale.
Questo articolo non è restituibile.
Consulta la politica di reso
Descrizione
The Recombinant Human IL-21 Protein is derived from E. coli. The Recombinant Human IL-21 Protein has been validated for the following applications: Bioactivity.
Specifica
Q9HBE4 | |
Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein. | |
Observed M.W.: 17kDa, reducing conditions, Theoretical M.W.: 15kDa | |
E. coli-derived human IL-21 protein Gln25-Ser155,with a N-terminal Met | |
<0.10 EU per 1μg of the protein by the LAL method. | |
IL-21 | |
Measured in a cell proliferation assay using N1186 human T cells. Parrish-Novak, J. et al. (2000) Nature 408:57. The ED50 for this effect is typically 2-12ng/mL. | |
Human | |
E. coli-derived Gln25-Ser155, with a N-terminal Met |
Bioactivity | |
59067 | |
10 μg | |
12 months from date of receipt, ≤ -20° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, ≤ -20° C under sterile conditions after reconstitution. | |
IL21, IL-21Za11interleukin-21, interleukin 21, interleukin-21 isoform | |
IL21 | |
Unconjugated | |
Recombinant | |
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining |
Correzione del contenuto del prodotto
Fornite il vostro feedback sul contenuto del prodotto compilando il modulo sottostante.
Titolo del prodotto
Individuate un'opportunità di miglioramento?Condividi una correzione di contenuto